Follow us on:

Linkedin Facebook

FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

GSK

GSK receives EU approval for Nucala in Eosinophilic COPD

GSK plc announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults with uncontrolled COPD characterised by raised blood eosinophils...
Vodafone Group

Vodafone delivers strong Q3 FY26 performance and reaffirms FY26 guidance

In Q3 FY26, Vodafone achieved strong service revenue growth across Europe and Africa, with continued momentum in Germany and Africa and good progress on the UK merger integration...
Shell plc

Shell plc Q4 2025 results reflect lower earnings and higher gearing

Shell plc’s unaudited fourth quarter 2025 results showed lower adjusted earnings and cash flow compared with the prior quarter, while full-year performance benefited from higher volumes, cost reductions and favourable tax movements despite lower commodity prices...
SSE Plc

SSE Plc Q3 Trading Update: EPS Guidance Maintained

SSE plc reports strong Q3 performance for the nine months to 31 December 2025, with a 64% increase in regulated networks investment and renewable output up 7% year on year...
GSK

GSK reports strong 2025 results and reaffirms long-term growth outlook

GSK delivered a strong financial performance in 2025, with sales of £32.7 billion driven by double-digit growth in Specialty Medicines across Respiratory, Immunology & Inflammation, Oncology and HIV...
DCC Energy

DCC Plc reports strong Q3 growth and maintains FY outlook

DCC plc reported strong adjusted operating profit growth in the third quarter ended 31 December 2025, driven by good organic performance and the first contribution from recent acquisitions...
Kingfisher plc

Kingfisher appoints Stephen Daintith as Non-Executive Director

Kingfisher plc has announced the appointment of Stephen Daintith to its Board as a Non-Executive Director and member of the Audit and Nomination Committees, effective 1 April 2026...
AstraZeneca

AstraZeneca Plc begins trading on the New York Stock Exchange

AstraZeneca has started trading its ordinary shares on the NYSE for the first time, aligning its listings across New York, London and Stockholm under a harmonised structure...
AstraZeneca

AstraZeneca signs $1.2bn obesity drug collaboration with CSPC

Under a new agreement with CSPC Pharmaceuticals, AstraZeneca will advance eight programmes targeting obesity and weight-related conditions, initially progressing four assets through Phase I...
Lloyds Banking Group

Lloyds reports strong 2025 performance and higher returns outlook

Lloyds Banking Group plc delivered a robust financial performance in 2025, with statutory profit before tax rising to £6.7 billion and return on tangible equity reaching 12.9%, or 14.8% excluding one-off charges...
3i Group Plc

3i Group FY2026 Q3 performance update: NAV growth driven by Action

3i Group reported a strong third quarter for FY2026, with NAV per share rising to 3,017 pence at 31 December 2025 and a total return of 20% for the nine months...
St. James's Place PLC

St. James’s Place reports record £220bn funds under management for 2025

St. James’s Place plc reported gross inflows of £21.9 billion for the year ended 31 December 2025, up 19% year on year, with net inflows rising 42% to £6.2 billion...
Endeavour Mining

Endeavour Mining delivers FY-2025 results with 1.21Moz production and record returns

Endeavour Mining plc released unaudited preliminary results for FY-2025, reporting gold production of 1.21 million ounces at an all-in sustaining cost of approximately $1,435 per ounce...
British Land

British Land to acquire Life Science REIT in recommended cash and share deal

British Land and Life Science REIT have reached agreement on a recommended acquisition structured as a court-sanctioned scheme of arrangement...
Gold

Fresnillo delivers gold above guidance in FY2025 Q4 production report

Fresnillo delivered solid operational performance in the fourth quarter of 2025, with full-year gold production exceeding guidance and silver production in line with expectations...
Sage Group plc

Sage Group delivers strong Q1 FY26 with accelerated organic growth

Sage Group plc achieved 10% organic revenue growth in the first quarter of FY26, supported by broad-based regional performance and continued adoption of its cloud and subscription solutions...
GSK

EU approves GSK’s Arexvy RSV vaccine for adults 18+

GSK plc announced that the European Commission has approved its RSV vaccine, Arexvy, for use in adults aged 18 years and older...
Babcock International

Babcock reports strong Q3 trading and confirms FY26 margin target

Babcock International Group reported continued strong performance in the third quarter, with organic revenue growth and further margin progression...
Associated British Foods

Associated British Food reports revenue in line with January estimates

Associated British Foods has reported group revenue of £6.8bn for the 16 weeks to 3 January 2026, broadly in line with estimates published on 8 January...
Gold

Fresnillo enters Canada with completion of Probe Gold acquisition

Fresnillo plc has finalised the acquisition of Probe Gold Inc. The transaction provides access to the Val d’Or district in Quebec, adds a large-scale gold resource anchored by the Novador project, and aligns with Fresnillo’s disciplined growth and exploration strategy...

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

May 10, 2024

GSK

GSK receives EU approval for Nucala in Eosinophilic COPD

GSK plc announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults with uncontrolled COPD characterised by raised blood eosinophils...
Vodafone Group

Vodafone delivers strong Q3 FY26 performance and reaffirms FY26 guidance

In Q3 FY26, Vodafone achieved strong service revenue growth across Europe and Africa, with continued momentum in Germany and Africa and good progress on the UK merger integration...
Shell plc

Shell plc Q4 2025 results reflect lower earnings and higher gearing

Shell plc’s unaudited fourth quarter 2025 results showed lower adjusted earnings and cash flow compared with the prior quarter, while full-year performance benefited from higher volumes, cost reductions and favourable tax movements despite lower commodity prices...
SSE Plc

SSE Plc Q3 Trading Update: EPS Guidance Maintained

SSE plc reports strong Q3 performance for the nine months to 31 December 2025, with a 64% increase in regulated networks investment and renewable output up 7% year on year...
GSK

GSK reports strong 2025 results and reaffirms long-term growth outlook

GSK delivered a strong financial performance in 2025, with sales of £32.7 billion driven by double-digit growth in Specialty Medicines across Respiratory, Immunology & Inflammation, Oncology and HIV...
DCC Energy

DCC Plc reports strong Q3 growth and maintains FY outlook

DCC plc reported strong adjusted operating profit growth in the third quarter ended 31 December 2025, driven by good organic performance and the first contribution from recent acquisitions...
Kingfisher plc

Kingfisher appoints Stephen Daintith as Non-Executive Director

Kingfisher plc has announced the appointment of Stephen Daintith to its Board as a Non-Executive Director and member of the Audit and Nomination Committees, effective 1 April 2026...
AstraZeneca

AstraZeneca Plc begins trading on the New York Stock Exchange

AstraZeneca has started trading its ordinary shares on the NYSE for the first time, aligning its listings across New York, London and Stockholm under a harmonised structure...
AstraZeneca

AstraZeneca signs $1.2bn obesity drug collaboration with CSPC

Under a new agreement with CSPC Pharmaceuticals, AstraZeneca will advance eight programmes targeting obesity and weight-related conditions, initially progressing four assets through Phase I...
Lloyds Banking Group

Lloyds reports strong 2025 performance and higher returns outlook

Lloyds Banking Group plc delivered a robust financial performance in 2025, with statutory profit before tax rising to £6.7 billion and return on tangible equity reaching 12.9%, or 14.8% excluding one-off charges...
3i Group Plc

3i Group FY2026 Q3 performance update: NAV growth driven by Action

3i Group reported a strong third quarter for FY2026, with NAV per share rising to 3,017 pence at 31 December 2025 and a total return of 20% for the nine months...
St. James's Place PLC

St. James’s Place reports record £220bn funds under management for 2025

St. James’s Place plc reported gross inflows of £21.9 billion for the year ended 31 December 2025, up 19% year on year, with net inflows rising 42% to £6.2 billion...
Endeavour Mining

Endeavour Mining delivers FY-2025 results with 1.21Moz production and record returns

Endeavour Mining plc released unaudited preliminary results for FY-2025, reporting gold production of 1.21 million ounces at an all-in sustaining cost of approximately $1,435 per ounce...
British Land

British Land to acquire Life Science REIT in recommended cash and share deal

British Land and Life Science REIT have reached agreement on a recommended acquisition structured as a court-sanctioned scheme of arrangement...
Gold

Fresnillo delivers gold above guidance in FY2025 Q4 production report

Fresnillo delivered solid operational performance in the fourth quarter of 2025, with full-year gold production exceeding guidance and silver production in line with expectations...
Sage Group plc

Sage Group delivers strong Q1 FY26 with accelerated organic growth

Sage Group plc achieved 10% organic revenue growth in the first quarter of FY26, supported by broad-based regional performance and continued adoption of its cloud and subscription solutions...
GSK

EU approves GSK’s Arexvy RSV vaccine for adults 18+

GSK plc announced that the European Commission has approved its RSV vaccine, Arexvy, for use in adults aged 18 years and older...
Babcock International

Babcock reports strong Q3 trading and confirms FY26 margin target

Babcock International Group reported continued strong performance in the third quarter, with organic revenue growth and further margin progression...
Associated British Foods

Associated British Food reports revenue in line with January estimates

Associated British Foods has reported group revenue of £6.8bn for the 16 weeks to 3 January 2026, broadly in line with estimates published on 8 January...
Gold

Fresnillo enters Canada with completion of Probe Gold acquisition

Fresnillo plc has finalised the acquisition of Probe Gold Inc. The transaction provides access to the Val d’Or district in Quebec, adds a large-scale gold resource anchored by the Novador project, and aligns with Fresnillo’s disciplined growth and exploration strategy...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

FTSE 100

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple